LYMPHOBLASTIC LYMPHOMA (PRECURSOR B-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Clinical trials for LYMPHOBLASTIC LYMPHOMA (PRECURSOR B-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LYMPHOMA (PRECURSOR B-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LYMPHOMA (PRECURSOR B-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with relapsed blood cancers: trial tests precision drug cocktail
Disease control Recruiting nowThis trial is testing a new combination of targeted drugs (ruxolitinib and venetoclax) with standard chemotherapy for children and young adults whose leukemia or lymphoma has come back or not responded to prior treatment. It aims to see if this approach is safe and effective for …
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR B-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for kids with relapsed blood cancers: trial tests precision drug cocktail
Disease control Recruiting nowThis trial is testing a new combination of targeted drugs for children and young adults whose acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) has come back or not responded to standard treatments. It aims to see if matching drugs to specific genetic changes in …
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR B-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for kids with tough blood cancers: trial tests precision medicine combo
Disease control Recruiting nowThis trial is testing a new combination of drugs for children and young adults whose leukemia or lymphoma has come back or hasn't responded to standard treatments. It specifically targets cancers with certain genetic changes. The goal is to see if adding a targeted drug called tr…
Matched conditions: LYMPHOBLASTIC LYMPHOMA (PRECURSOR B-LYMPHOBLASTIC LYMPHOMA/LEUKAEMIA) REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC